Screening 80 known kinase inhibitors with waveRAPID, a Creoptix technology

Inicie sesión para ver este seminario web

¿Olvidó su contraseña?
¿Aún no estás registrado? Crea una cuenta

Learn how the waveRAPID, a Creoptix technology, supports screening of 80 known kinase inhibitors to p38. 

Our team discuss:

  • the screening process
  • Ligand immobilization
  • Positive control establishment
  • Review of screening results (non binding, non-specific binders, binders/HITs)
  • validation of HITs using Multicycle Kinetics